Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Natalizumab-induced autoimmune hepatitis in a patient with multiple sclerosis.
Characteristic cerebrospinal fluid cytokine/chemokine profiles in neuromyelitis optica, relapsing remitting or primary progressive multiple sclerosis.
Indicators for cognitive performance and subjective cognitive complaints in multiple sclerosis: a role for advanced MRI?
Biologic therapies: lessons from multiple sclerosis.
Natalizumab Discontinuation and Treatment Strategies in Patients with Multiple Sclerosis (MS): A Retrospective Study from Two Italian MS Centers.
Effects of cannabis on cognition in patients with MS: A psychometric and MRI study.
Are there Epstein-Barr virus seronegative patients with multiple sclerosis?
Minoderm
Stable antigen-specific T-cell hyporesponsiveness induced by tolerogenic dendritic cells from multiple sclerosis patients.
Fatigue and Depression in Children With Demyelinating Disorders.
Patients' experiences of adapting to multiple sclerosis: a qualitative study.
[Differential diagnosis of late-stage neuroborreliosis with affection of the central nervous system.]
Role of Platelets in Neurodegenerative Diseases: A Universal Pathophysiology.
Fulminant Central Plus Peripheral Nervous System Demyelination without Antibodies to Neurofascin.
Protective effects of ginseng on neurological disorders.
Influence of treatments in multiple sclerosis disability: A cohort study.
Combined treatment with minocycline and prednisone attenuates experimental autoimmune encephalomyelitis in C57 BL/6 mice.
Proteomic analysis of the anti-inflammatory action of minocycline.
Treatment with the interleukin-17A-blocking antibody secukinumab does not interfere with the efficacy of influenza and meningococcal vaccinations in healthy subjects: results of an open-label, parallel-group, randomized single-center study.
Incidence of therapy-related acute leukaemia in mitoxantrone-treated multiple sclerosis patients in Germany.
Perceived impact of spasticity is associated with spatial and temporal parameters of gait in multiple sclerosis.
Dynamics of saccade parameters in multiple sclerosis patients with fatigue.
Coping Strategies in Multiple Sclerosis Patients with Frontal Cognitive Disorders.
The roles of cathelicidin LL-37 in immune defences and novel clinical applications.
Can we safely target the WNT pathway?

Pages